Globus acquires Nevro for their spinal cord stimulation for $250M

In simple terms, Nevro Corp. focuses on developing and providing medical devices that help manage chronic pain. They are known for their HFX spinal cord stimulation (SCS) system, which involves implanting a device that sends electrical signals to the spinal cord to reduce pain. This technology is particularly used for conditions like chronic back pain and painful diabetic neuropathy, aiming to offer significant relief without the need for medication or surgery.

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device comp...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top